Sealed Air Continues to Play Critical Role in Packaging Solutions to Support COVID-19 Needs
Sealed Air Corporation (NYSE: SEE) is enhancing its role in the COVID-19 response by providing essential packaging solutions such as automated systems for medical equipment and temperature assurance materials for vaccine distribution. The launch of TemPreserve KF, a customizable thermal polyurethane packaging, aims to reduce costs while bolstering sustainability. With over 30 years of experience in health care packaging, Sealed Air operates ISTA-certified labs globally, ensuring effective logistics for temperature-sensitive items. The company generated $4.8 billion in sales in 2019 and continues to support a safer supply chain amidst the pandemic.
- Introduction of TemPreserve KF to enhance temperature assurance and sustainability.
- Established presence in health care packaging with over 30 years of experience.
- IST-certified labs globally to ensure effective packaging solutions.
- Strong sales of $4.8 billion in 2019 indicating robust market position.
- None.
As an industry leader in sustainable packaging solutions and systems, Sealed Air Corporation (NYSE: SEE) is proud to play a role in providing the essential packaging solutions needed to help customers in the fight against COVID-19.
Sealed Air provides customers with packaging solutions including custom-fabricated shipping boxes, and automated packaging and bagging systems that enable the distribution of medical equipment, face coverings, and test kits. Sealed Air is also supporting vaccine distribution and administration by offering a complete range of temperature assurance materials that can be used in packaging vials that require a cold supply chain, including during the critical last mile of delivery.
Sealed Air is introducing a new innovation called SEALED AIR© brand TemPreserve KF that will reduce total cost of ownership and bring additional sustainability benefits. TemPreserve KF is a customizable thermal polyurethane packaging that, along with a coolant, helps maintain required temperatures (ultra-cold, cold or hot) for the specific length of time needed during transit.
“We are proud to offer customers a full suite of packaging solutions as they prioritize getting the right equipment, test kits, and vaccines to the world’s population as quickly and safely as possible,” said Sergio Pupkin, Sealed Air’s Chief Growth and Strategy officer.
Global Resources and Expertise
Sealed Air has produced packaging solutions for the health care industry for more than 30 years and is well equipped to support health care packaging solutions throughout the entire cold chain and logistics cycle, including the last mile of delivery.
The company operates two temperature assurance labs that focus on the design and testing of products that protect temperature-sensitive and perishable items for the life sciences and food industries. Located in Singapore and at Sealed Air’s global corporate headquarters in Charlotte, North Carolina, these International Safe Transit Association (ISTA) Standard 20 certified labs can support customers globally.
Across the company’s global footprint are more than a dozen labs and thermal transport laboratories certified by ISTA as well as 42 testing locations worldwide that design, test, and certify packaging.
More information about how Sealed Air packaging solutions are helping the world respond to COVID-19, can be found on this webpage.
A high-resolution photo of TemPreserve KF is available upon request.
About Sealed Air
Sealed Air is in business to protect, to solve critical packaging challenges, and to leave our world better than we found it. Our portfolio of leading packaging solutions includes CRYOVAC® brand food packaging, SEALED AIR® brand protective packaging, AUTOBAG ® brand automated systems, and BUBBLE WRAP® brand packaging, which collectively enable a safer, more efficient food supply chain and protect valuable goods shipped around the world. Sealed Air generated
Website Information
We routinely post important information for investors on our website, sealedair.com, in the Investors section. We use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 concerning our business, consolidated financial condition and results of operations. Forward-looking statements are subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can be identified by such words as “anticipate,” “believe,” “plan,” “assume,” “could,” “should,” “estimate,” “expect,” “intend,” “potential,” “seek,” “predict,” “may,” “will” and similar references to future periods. All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results, expectations regarding the results of restructuring and other programs, anticipated levels of capital expenditures and expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings. The following are important factors that we believe could cause actual results to differ materially from those in our forward-looking statements: global economic and political conditions, currency translation and devaluation effects, changes in raw material pricing and availability, competitive conditions, the success of new product offerings, consumer preferences, the effects of animal and food-related health issues, pandemics, changes in energy costs, environmental matters, the success of our restructuring activities, the success of our financial growth, profitability, cash generation and manufacturing strategies and our cost reduction and productivity efforts, changes in our credit ratings, the tax benefit associated with the Settlement agreement (as defined in our most recent Annual Report on Form 10-K), regulatory actions and legal matters, and the other information referenced in the “Risk Factors” section appearing in our most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, and as revised and updated by our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Any forward-looking statement made by us is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210114006006/en/
FAQ
What is Sealed Air's role in COVID-19 response?
What new product has Sealed Air introduced?
How long has Sealed Air been in the health care packaging industry?
What were Sealed Air's sales figures in 2019?
Where are Sealed Air's temperature assurance labs located?
